[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 204
Citations 0
Correction
June 17, 2020

Errors in Abstract, Results, and End Matter

JAMA Cardiol. Published online June 17, 2020. doi:10.1001/jamacardio.2020.2302

The Brief Report “Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19),”1 published online on May 1, 2020, contained 3 errors. The first was a misstated percentage in the Abstract and Results. The phrase “3 patients (3%)” should have said “3 patients (8%).” In addition, a percentage in the Results section was missing a decimal point. The phrase “(26 patients [289%]…)” should have said “(26 patients [28.9%]…).” Finally, the Corresponding Author information for Howard S. Gold, MD, and Peter J. Zimetbaum, MD, was inadvertently omitted and has been added. The article has been corrected online.

References
1.
Mercuro  NJ, Yen  CF, Shim  DJ,  et al.  Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19).   JAMA Cardiol. Published online May 1, 2020. doi:10.1001/jamacardio.2020.1834PubMedGoogle Scholar
×